First County Bank CT Sells 374 Shares of Danaher Co. (NYSE:DHR)

First County Bank CT lessened its holdings in Danaher Co. (NYSE:DHRFree Report) by 19.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,588 shares of the conglomerate’s stock after selling 374 shares during the quarter. First County Bank CT’s holdings in Danaher were worth $365,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in DHR. Teachers Insurance & Annuity Association of America bought a new stake in Danaher in the third quarter valued at about $39,000. MidAtlantic Capital Management Inc. bought a new stake in shares of Danaher in the 3rd quarter valued at approximately $40,000. FSA Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter worth approximately $50,000. Darwin Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth approximately $55,000. Finally, Modus Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at $56,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. UBS Group dropped their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Citigroup cut their price target on shares of Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a report on Monday. Robert W. Baird decreased their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Scotiabank assumed coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Finally, Stifel Nicolaus increased their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $286.80.

Check Out Our Latest Research Report on Danaher

Danaher Trading Up 0.6 %

DHR stock traded up $1.45 during midday trading on Tuesday, reaching $239.65. The company’s stock had a trading volume of 1,763,681 shares, compared to its average volume of 2,621,022. The business’s 50-day simple moving average is $236.25 and its 200-day simple moving average is $254.22. The stock has a market cap of $173.09 billion, a PE ratio of 45.73, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. Danaher Co. has a 52 week low of $222.53 and a 52 week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter in the prior year, the company posted $2.02 earnings per share. The firm’s revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is currently 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.